Sermorelin is a synthetic 29-amino-acid peptide and the shortest fragment of human growth hormone-releasing hormone (GHRH) that retains full biological activity. It is studied as a way to stimulate the pituitary gland to release the body's own growth hormone, rather than supplying GH directly. It is a research compound and is not intended for personal medical use.[5]

How does Sermorelin work?

Sermorelin binds to GHRH receptors on the pituitary gland and triggers a pulse of natural growth hormone release. That GH then stimulates IGF-1 production in the liver and other tissues, which supports processes like cell repair and growth. Because it works through the body's own signaling system, it preserves natural feedback loops that direct GH administration would bypass.[2][5]

What is Sermorelin used for in research?

Research has focused on two main areas: diagnosing GH deficiency using a single provocative dose, and treating idiopathic GH deficiency in prepubertal children to improve height velocity over 12–36 months.[5] It is also explored in adult GH insufficiency,[2] musculoskeletal recovery,[1] and early-stage oncology research involving recurrent glioma.[4]

How is Sermorelin dosed?

Doses depend heavily on the research context. A single intravenous dose has been used for diagnostic provocative testing, while a daily subcutaneous dose given at bedtime has been studied for long-term treatment of GH deficiency in children.[5] See the dosage chart on this page for the specific figures, and use the calculator to explore weight-based scaling.

How do you reconstitute Sermorelin?

Sermorelin powder is typically mixed with bacteriostatic water. Inject the water slowly down the inside wall of the vial — not directly onto the powder — then gently swirl to dissolve. Never shake the vial. Once mixed, store the solution refrigerated at 2–8 °C and use within the timeframe specified by the supplier. The solution should be clear before use.

In clinical trials, single intravenous and repeated daily subcutaneous doses were generally well tolerated. The most commonly reported side effects were transient facial flushing and pain at the injection site.[5] However, rigorous human safety data in newer research contexts — such as musculoskeletal or anti-aging applications — remain scarce.[6] Sermorelin is a research compound; consult a qualified professional for any health-related questions.

Sermorelin Dosage Chart, Protocol & Calculator

A GHRH fragment studied for endogenous GH release.

Objectif	Dose	Fréquence	Durée	Preuve	Source
Provocative test for growth hormone deficiency (diagnosis)	1 mcg	single dose	per trial	Clinical	PMID 18031173
Treatment of idiopathic growth hormone deficiency in prepubertal children	30 mcg	1x/day	12-36 months	Clinical	PMID 18031173

What is Sermorelin?

Sermorelin is a synthetic peptide made up of 29 amino acids. Think of amino acids as tiny building blocks — proteins are built from them, and so are peptides. Sermorelin is a shortened version of a natural hormone called growth hormone-releasing hormone (GHRH). Remarkably, those 29 amino acids are all the body needs to trigger the same response as the full-length natural molecule.^[5]

In the research world, sermorelin is classified as a growth hormone secretagogue — a fancy term for something that prompts the body to release its own growth hormone (GH), rather than supplying GH directly from outside.^[2] It is also grouped with other GHRH analogs like tesamorelin and CJC-1295, which researchers study for similar reasons.^[3]

Important note: Sermorelin is a research compound. Nothing on this page is medical advice, and this information is provided for educational and scientific reference only.

How Sermorelin Works

Here is a simple way to picture it. Your pituitary gland — a pea-sized gland at the base of your brain — is like a factory that makes growth hormone. But it needs a signal before it gets to work. Sermorelin acts like a doorbell. It binds to a specific receptor on the pituitary gland, rings the bell, and the factory releases a burst of GH.^[5]

That GH then travels through the bloodstream and prompts the liver and other tissues to produce another hormone called IGF-1 (insulin-like growth factor 1). IGF-1 is what actually gets into cells and drives processes like tissue repair and muscle maintenance.^[1] Because sermorelin works through the body's own system rather than bypassing it, researchers consider this an indirect approach — one that preserves the body's natural feedback loops.

What the Research Shows

Most of the solid clinical research on sermorelin comes from its use as a diagnostic tool and as a treatment in children with growth hormone deficiency.

Diagnosing GH deficiency: A single intravenous dose of sermorelin can provoke a measurable GH response, making it useful as a diagnostic challenge test. Researchers have noted that it produces fewer false-positive results compared to some other provocative tests.^[5]
Treating children with idiopathic GH deficiency: Studies found that daily subcutaneous (under-the-skin) injections of sermorelin produced meaningful increases in height velocity — how fast children were growing — sustained over 12 months and, in some cases, up to 36 months of continued treatment.^[5]
Adult GH insufficiency: Some researchers have argued that stimulating the body's own GH release with sermorelin may be a more physiologically natural approach than directly administering synthetic GH, because it keeps natural feedback mechanisms intact.^[2]
Musculoskeletal and sports medicine context: Sermorelin is mentioned alongside other GH secretagogues in reviews of peptides studied for tissue repair and recovery. Reviewers note that while preclinical results look interesting, rigorous human safety data in this context are still scarce.^[6]
Oncology — early-stage research: One computational study screened thousands of drugs against glioma (a type of brain tumor) gene-expression data and flagged sermorelin as potentially sensitive in recurrent, high-grade cases. Researchers suggested it may work by blocking the cell cycle and modulating immune pathways. This is very early-stage, hypothesis-generating research.^[4]
Anti-doping detection: Because GHRH analogs including sermorelin are prohibited by the World Anti-Doping Agency (WADA), researchers have developed laboratory methods to detect sermorelin and its metabolites in urine, helping enforce fair play in sport.^[3]

What Sermorelin Is Being Studied For

Diagnosing growth hormone deficiency (GHD)
Promoting growth in children with idiopathic GHD^[5]
Managing adult-onset growth hormone insufficiency^[2]
Supporting tissue repair and recovery in a musculoskeletal research context^[1]
Exploratory oncology research, specifically recurrent glioma^[4]

How Sermorelin Is Dosed in Research

Doses vary considerably depending on the research context — a single diagnostic challenge looks very different from a long-term treatment protocol. The dosage chart on this page lays out the key reference doses used in published studies, including the single-dose protocol used in provocative testing and the daily dosing schedule studied in prepubertal children. Use the interactive calculator on this page to explore how those weight-based doses scale. Always note that these figures come from specific clinical trials and should be interpreted strictly within that research framework.^[5]

Mixing and Storing Sermorelin

In research settings, sermorelin typically arrives as a lyophilized powder — that means freeze-dried. Before use, it must be reconstituted (mixed back into a liquid), usually with bacteriostatic water (sterile water with a small amount of benzyl alcohol to prevent microbial growth). The general principle is to inject the water slowly down the side of the vial — not directly onto the powder — and then gently swirl, never shake, to avoid breaking the peptide chains. Once reconstituted, sermorelin should be kept refrigerated (around 2–8 °C / 36–46 °F) and is typically stable for a limited period as specified by the manufacturer or supplier. Unused reconstituted solution should not be frozen. Always inspect the solution before use: it should be clear and free of particles. These are general research-handling principles; always follow the specific instructions provided with your research material.

Sources

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200.
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? — Clinical interventions in aging, 2006. PMID 18046908.
Advances in the detection of growth hormone releasing hormone synthetic analogs. — Drug testing and analysis, 2021. PMID 34665524.
A potentially effective drug for patients with recurrent glioma: sermorelin. — Annals of translational medicine, 2021. PMID 33842627.
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. — BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 1999. PMID 18031173.
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. — Sports medicine (Auckland, N.Z.), 2026. PMID 41966639.

Sermorelin Guide & Tableau de Dose